Results 191 to 200 of about 12,569 (300)

Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer's disease. [PDF]

Alzheimers Dement
Gogola A, Zeng X, Williams LA, Chapple-McGruder T, Saeed A, Lopresti BJ, Snitz B, Tudorascu D, Minhas D, Ikonomovic MD, Kofler J, Matan C, Pascoal TA, Aizenstein H, Zetterberg H, Blennow K, Lopez O, Villemagne VL, Karikari TK, Cohen AD.   +19 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Measuring inequities in transportation injuries in a Canadian commuter cohort: impacts of individual versus neighbourhood income. [PDF]

Inj Epidemiol
Yeo RE, Branion-Calles M, Rothman L, Winters M, Harris MA.   +4 more
europepmc   +1 more source

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Canagliflozin was recently approved in type 2 diabetes mellitus (T2DM) patients ≥10 and <18 years old as a single agent dosed once daily (QD) or in a fixed‐dose combination with metformin dosed twice daily (BID). We characterize canagliflozin pharmacokinetics in paediatric patients with T2DM, compare estimated individual and simulated ...
Nele Goeyvaerts, Per Olsson Gisleskog, Martine Neyens, Juan José Perez Ruixo, Saberi Rana Ali, Iolanda Cirillo, Oliver Ackaert   +6 more
wiley   +1 more source

"I Just Get a Different Feeling in This Class": Belonging as Affective Praxis at a Dutch Urban Secondary Education School. [PDF]

J Community Psychol
Çolak FZ, Parra SL, Wansink B.
europepmc   +1 more source

We ought to discuss the social construction of cadavers: Here's why and how

Anatomical Sciences Education, EarlyView.
Fatima Ehsan, Susan Lamb
wiley   +1 more source

The impact of pharmacogenetic‐informed care on medication adherence and psychological factors associated with adherence: A narrative review

British Journal of Clinical Pharmacology, EarlyView.
Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic‐guided prescribing over a traditional one‐size‐fits‐all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic‐informed care, or that ...
Lucy Galloway, Alison Wright, John Weinman   +2 more
wiley   +1 more source

Is pharmacogenetics being racialized? An investigation into the reinscription of racial beliefs in modern biomedicine. [PDF]

Theor Med Bioeth
Steimle L, Schües C.
europepmc   +1 more source

Reconceptualising ‘agency in mobility’: Agency for becoming and other forms of agency in study abroad

British Educational Research Journal, EarlyView.
Abstract Study‐abroad programs are increasingly adopted and supported by institutions and governments as a strategic tool for deepening internationalisation and public diplomacy through people‐to‐people, institution‐to‐institution and country‐to‐country connections.
Ly Thi Tran, Thinh Huynh
wiley   +1 more source